Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

Historical Holders from Q1 2021 to Q3 2025

Symbol
PHVS on Nasdaq
Type / Class
Equity / Ordinary Shares, Euro 0.12 par value per share
Shares outstanding
62,254,300
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
57,844,608
Holdings value
$1,443,142,875
% of all portfolios
0.02%
Number of holders
83
Number of buys
66
Number of sells
-14
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Venrock Healthcare Capital Partners III, L.P. 3.8% $51,436,214 2,047,620 Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
Bain Capital Life Sciences Fund, L.P. 3% $46,597,344 1,867,629 Bain Capital Life Sciences Fund, L.P. 30 Sep 2025

Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 57,844,608 $1,443,142,875 +$236,461,386 $24.95 83
2025 Q2 45,040,180 $792,712,813 +$1,806,103 $17.6 60
2025 Q1 44,939,067 $705,543,867 +$4,132,739 $15.7 52
2024 Q4 44,644,168 $855,824,077 -$7,190,155 $19.17 54
2024 Q3 45,045,428 $834,243,398 +$34,119,580 $18.52 51
2024 Q2 43,008,763 $808,565,649 +$10,680,383 $18.8 36
2024 Q1 42,425,740 $980,459,437 +$36,728,417 $23.11 35
2023 Q4 40,745,703 $1,142,917,292 +$327,949,428 $28.05 36
2023 Q3 29,067,102 $606,630,419 +$4,468,799 $20.87 21
2023 Q2 28,913,752 $441,577,880 +$109,619,000 $15.14 21
2023 Q1 21,781,494 $173,888,454 +$3,756,313 $8.06 21
2022 Q4 21,301,855 $239,644,411 -$1,830,525 $11.25 25
2022 Q3 22,314,954 $173,600,000 -$317,120 $7.67 21
2022 Q2 22,353,338 $494,009,000 +$14,911,660 $22.1 20
2022 Q1 21,685,388 $397,090,000 +$838,867 $18.14 22
2021 Q4 21,647,018 $321,068,000 -$1,695,268 $14.39 22
2021 Q3 21,631,638 $380,302,000 -$6,827,497 $17.73 25
2021 Q2 21,995,815 $406,288,000 -$1,442,853 $18.62 28
2021 Q1 22,025,122 $616,507,000 +$616,507,000 $27.99 33